Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Mizuho analyst Salim Syed initiated coverage on Sutro Biopharma Inc (NASDAQ:STRO) with an Outperform rating and announced a price target of $50. Sutro Biopharma shares closed at $35.39 on Wednesday. See how other analysts view this stock.
- Oppenheimer analyst Param Singh initiated coverage on Palantir Technologies Inc (NASDAQ:PLTR) with an Outperform rating and announced a price target of $200. Palantir shares closed at $137.97 on Wednesday. See how other analysts view this stock.
Considering buying PLTR stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments